Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 2/3 1

Status

Completed 4Unknown 3Terminated 2Not yet recruiting 2

Sponsor Class

OTHER 3OTHER_GOV 1NIH 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 1Genitourinary 1Classical hematology 1

Conditions

Neoplasms 2Sepsis 1Prostatic Neoplasms 1Febrile Neutropenia 1Emergencies 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER × Levofloxacin × Clear all
NCT05393505 2022-12-06

FRANCiS-NF

The University of Hong Kong

Phase 4 Unknown
344 enrolled
Classical hematology

Emergencies, Neoplasms, Sepsis, Febrile Neutropenia

NCT02757365 2016-05-02

Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer

West China Hospital

Phase 4 Unknown
100 enrolled
Genitourinary

Prostatic Neoplasms

NCT00215007 2007-11-30

Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)

Charite University, Berlin, Germany

Phase 2/3 Unknown
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡